Chester County News and Community Website
MALVERN, PA — Endo, Inc. this week unveiled a new television commercial and disease awareness campaign, titled “Reminders,” aimed at empowering patients to advocate for their treatment preferences for Dupuytren’s …
Endo Launches “Reminders” Campaign to Empower Patients with Dupuytren’s Contracture Read More
MALVERN, PA — In a significant advancement for retinitis pigmentosa (RP) treatment, Ocugen, Inc. (NASDAQ: OCGN) has received favorable scientific advice from the European Medicines Agency (EMA) regarding its pivotal …
Ocugen’s Gene Therapy OCU400 Moves Closer to European Market with EMA’s Positive Opinion Read More
PLYMOUTH MEETING, PA — In a significant development for patients with Prader-Willi syndrome (PWS), Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently announced the initiation of a global Phase 3 registrational …
Harmony Biosciences Launches Phase 3 Trial for Potential Prader-Willi Syndrome Treatment Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to its investigational therapy, CABA-201. This designation …
Cabaletta Bio Receives FDA Orphan Drug Designation for Innovative Autoimmune Disease Therapy Read More